About Us Services Careers FAQ Contact Us 0
Home Pharmaceuticals Natural Killer (NK) Cell Therapeutics Market Size, Growth & Statistics - 2031

Natural Killer (NK) Cell Therapeutics Market

Natural Killer (NK) Cell Therapeutics Market Size, Share & Trends Analysis Report By Natural Killer (NK) cell Therapy Type (NK Cell Therapy (unmodified), CAR-NK Cell Therapy (modified), NK Cell Engager), By Approaches (Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC), Bispecific Antibodies), By Application (Cancer, Immunoproliferative Disorders, Acute Infectious Diseases, Gastrointestinal Diseases, Others), By Indication (Hepatocellular Carcinoma (HCC), Acute Myeloid Leukemia (AML), Relapsed Or Refractory (r/r) B-Cell Non-Hodgkin's Lymphoma (NHL), Peripheral T-Cell Lymphoma (PTCL).), By Pipeline Product (AFM13, MG4101, GTA002 (oNKordA), TAK-007) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRPH54334DR
Study Period 2019-2031 CAGR 44.3%
Historical Period 2019-2021 Forecast Period 2023-2031
Base Year 2022 Base Year Market Size USD 92 Million
Forecast Year 2031 Forecast Year Market Size USD 3160 Million
Largest Market North America Fastest Growing Market Europe
Show More
Buy Now
File Formats
The sample report only takes 30 secs to download, no need to wait longer.

Market Segmentation

  1. Natural Killer (NK) Cell Therapeutics Market, By Natural Killer (NK) cell Therapy Type (2021-2031)
    1. NK Cell Therapy (unmodified)
    2. CAR-NK Cell Therapy (modified)
    3. NK Cell Engager
  2. Natural Killer (NK) Cell Therapeutics Market, By Approaches (2021-2031)
    1. Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
    2. Bispecific Antibodies
  3. Natural Killer (NK) Cell Therapeutics Market, By Application (2021-2031)
    1. Cancer
    2. Immunoproliferative Disorders
    3. Acute Infectious Diseases
    4. Gastrointestinal Diseases
    5. Others
  4. Natural Killer (NK) Cell Therapeutics Market, By Indication (2021-2031)
    1. Hepatocellular Carcinoma (HCC)
    2. Acute Myeloid Leukemia (AML)
    3. Relapsed Or Refractory (r/r) B-Cell Non-Hodgkin's Lymphoma (NHL)
    4. Peripheral T-Cell Lymphoma (PTCL).
  5. Natural Killer (NK) Cell Therapeutics Market, By Pipeline Product (2021-2031)
    1. AFM13
    2. MG4101
    3. GTA002 (oNKordA)
    4. TAK-007
    1. North America
      1. North America Natural Killer (NK) Cell Therapeutics Market, By Natural Killer (NK) cell Therapy Type
        1. NK Cell Therapy (unmodified)
          1. CAR-NK Cell Therapy (modified)
            1. NK Cell Engager
            2. North America Natural Killer (NK) Cell Therapeutics Market, By Approaches
              1. Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
                1. Bispecific Antibodies
                2. North America Natural Killer (NK) Cell Therapeutics Market, By Application
                  1. Cancer
                    1. Immunoproliferative Disorders
                      1. Acute Infectious Diseases
                        1. Gastrointestinal Diseases
                          1. Others
                          2. North America Natural Killer (NK) Cell Therapeutics Market, By Indication
                            1. Hepatocellular Carcinoma (HCC)
                              1. Acute Myeloid Leukemia (AML)
                                1. Relapsed Or Refractory (r/r) B-Cell Non-Hodgkin's Lymphoma (NHL)
                                  1. Peripheral T-Cell Lymphoma (PTCL).
                                  2. North America Natural Killer (NK) Cell Therapeutics Market, By Pipeline Product
                                    1. AFM13
                                      1. MG4101
                                        1. GTA002 (oNKordA)
                                          1. TAK-007
                                          2. U.S.
                                            1. U.S. Natural Killer (NK) Cell Therapeutics Market, By Natural Killer (NK) cell Therapy Type
                                              1. NK Cell Therapy (unmodified)
                                                1. CAR-NK Cell Therapy (modified)
                                                  1. NK Cell Engager
                                                  2. U.S. Natural Killer (NK) Cell Therapeutics Market, By Approaches
                                                    1. Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
                                                      1. Bispecific Antibodies
                                                      2. U.S. Natural Killer (NK) Cell Therapeutics Market, By Application
                                                        1. Cancer
                                                          1. Immunoproliferative Disorders
                                                            1. Acute Infectious Diseases
                                                              1. Gastrointestinal Diseases
                                                                1. Others
                                                                2. U.S. Natural Killer (NK) Cell Therapeutics Market, By Indication
                                                                  1. Hepatocellular Carcinoma (HCC)
                                                                    1. Acute Myeloid Leukemia (AML)
                                                                      1. Relapsed Or Refractory (r/r) B-Cell Non-Hodgkin's Lymphoma (NHL)
                                                                        1. Peripheral T-Cell Lymphoma (PTCL).
                                                                        2. U.S. Natural Killer (NK) Cell Therapeutics Market, By Pipeline Product
                                                                          1. AFM13
                                                                            1. MG4101
                                                                              1. GTA002 (oNKordA)
                                                                                1. TAK-007
                                                                              2. Canada
                                                                            2. Europe
                                                                              1. Europe Natural Killer (NK) Cell Therapeutics Market, By Natural Killer (NK) cell Therapy Type
                                                                                1. NK Cell Therapy (unmodified)
                                                                                  1. CAR-NK Cell Therapy (modified)
                                                                                    1. NK Cell Engager
                                                                                    2. Europe Natural Killer (NK) Cell Therapeutics Market, By Approaches
                                                                                      1. Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
                                                                                        1. Bispecific Antibodies
                                                                                        2. Europe Natural Killer (NK) Cell Therapeutics Market, By Application
                                                                                          1. Cancer
                                                                                            1. Immunoproliferative Disorders
                                                                                              1. Acute Infectious Diseases
                                                                                                1. Gastrointestinal Diseases
                                                                                                  1. Others
                                                                                                  2. Europe Natural Killer (NK) Cell Therapeutics Market, By Indication
                                                                                                    1. Hepatocellular Carcinoma (HCC)
                                                                                                      1. Acute Myeloid Leukemia (AML)
                                                                                                        1. Relapsed Or Refractory (r/r) B-Cell Non-Hodgkin's Lymphoma (NHL)
                                                                                                          1. Peripheral T-Cell Lymphoma (PTCL).
                                                                                                          2. Europe Natural Killer (NK) Cell Therapeutics Market, By Pipeline Product
                                                                                                            1. AFM13
                                                                                                              1. MG4101
                                                                                                                1. GTA002 (oNKordA)
                                                                                                                  1. TAK-007
                                                                                                                  2. U.K.
                                                                                                                    1. U.K. Natural Killer (NK) Cell Therapeutics Market, By Natural Killer (NK) cell Therapy Type
                                                                                                                      1. NK Cell Therapy (unmodified)
                                                                                                                        1. CAR-NK Cell Therapy (modified)
                                                                                                                          1. NK Cell Engager
                                                                                                                          2. U.K. Natural Killer (NK) Cell Therapeutics Market, By Approaches
                                                                                                                            1. Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
                                                                                                                              1. Bispecific Antibodies
                                                                                                                              2. U.K. Natural Killer (NK) Cell Therapeutics Market, By Application
                                                                                                                                1. Cancer
                                                                                                                                  1. Immunoproliferative Disorders
                                                                                                                                    1. Acute Infectious Diseases
                                                                                                                                      1. Gastrointestinal Diseases
                                                                                                                                        1. Others
                                                                                                                                        2. U.K. Natural Killer (NK) Cell Therapeutics Market, By Indication
                                                                                                                                          1. Hepatocellular Carcinoma (HCC)
                                                                                                                                            1. Acute Myeloid Leukemia (AML)
                                                                                                                                              1. Relapsed Or Refractory (r/r) B-Cell Non-Hodgkin's Lymphoma (NHL)
                                                                                                                                                1. Peripheral T-Cell Lymphoma (PTCL).
                                                                                                                                                2. U.K. Natural Killer (NK) Cell Therapeutics Market, By Pipeline Product
                                                                                                                                                  1. AFM13
                                                                                                                                                    1. MG4101
                                                                                                                                                      1. GTA002 (oNKordA)
                                                                                                                                                        1. TAK-007
                                                                                                                                                      2. Germany
                                                                                                                                                      3. France
                                                                                                                                                      4. Spain
                                                                                                                                                      5. Italy
                                                                                                                                                      6. Russia
                                                                                                                                                      7. Nordic
                                                                                                                                                      8. Benelux
                                                                                                                                                      9. Rest of Europe
                                                                                                                                                    2. APAC
                                                                                                                                                      1. APAC Natural Killer (NK) Cell Therapeutics Market, By Natural Killer (NK) cell Therapy Type
                                                                                                                                                        1. NK Cell Therapy (unmodified)
                                                                                                                                                          1. CAR-NK Cell Therapy (modified)
                                                                                                                                                            1. NK Cell Engager
                                                                                                                                                            2. APAC Natural Killer (NK) Cell Therapeutics Market, By Approaches
                                                                                                                                                              1. Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
                                                                                                                                                                1. Bispecific Antibodies
                                                                                                                                                                2. APAC Natural Killer (NK) Cell Therapeutics Market, By Application
                                                                                                                                                                  1. Cancer
                                                                                                                                                                    1. Immunoproliferative Disorders
                                                                                                                                                                      1. Acute Infectious Diseases
                                                                                                                                                                        1. Gastrointestinal Diseases
                                                                                                                                                                          1. Others
                                                                                                                                                                          2. APAC Natural Killer (NK) Cell Therapeutics Market, By Indication
                                                                                                                                                                            1. Hepatocellular Carcinoma (HCC)
                                                                                                                                                                              1. Acute Myeloid Leukemia (AML)
                                                                                                                                                                                1. Relapsed Or Refractory (r/r) B-Cell Non-Hodgkin's Lymphoma (NHL)
                                                                                                                                                                                  1. Peripheral T-Cell Lymphoma (PTCL).
                                                                                                                                                                                  2. APAC Natural Killer (NK) Cell Therapeutics Market, By Pipeline Product
                                                                                                                                                                                    1. AFM13
                                                                                                                                                                                      1. MG4101
                                                                                                                                                                                        1. GTA002 (oNKordA)
                                                                                                                                                                                          1. TAK-007
                                                                                                                                                                                          2. China
                                                                                                                                                                                            1. China Natural Killer (NK) Cell Therapeutics Market, By Natural Killer (NK) cell Therapy Type
                                                                                                                                                                                              1. NK Cell Therapy (unmodified)
                                                                                                                                                                                                1. CAR-NK Cell Therapy (modified)
                                                                                                                                                                                                  1. NK Cell Engager
                                                                                                                                                                                                  2. China Natural Killer (NK) Cell Therapeutics Market, By Approaches
                                                                                                                                                                                                    1. Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
                                                                                                                                                                                                      1. Bispecific Antibodies
                                                                                                                                                                                                      2. China Natural Killer (NK) Cell Therapeutics Market, By Application
                                                                                                                                                                                                        1. Cancer
                                                                                                                                                                                                          1. Immunoproliferative Disorders
                                                                                                                                                                                                            1. Acute Infectious Diseases
                                                                                                                                                                                                              1. Gastrointestinal Diseases
                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                2. China Natural Killer (NK) Cell Therapeutics Market, By Indication
                                                                                                                                                                                                                  1. Hepatocellular Carcinoma (HCC)
                                                                                                                                                                                                                    1. Acute Myeloid Leukemia (AML)
                                                                                                                                                                                                                      1. Relapsed Or Refractory (r/r) B-Cell Non-Hodgkin's Lymphoma (NHL)
                                                                                                                                                                                                                        1. Peripheral T-Cell Lymphoma (PTCL).
                                                                                                                                                                                                                        2. China Natural Killer (NK) Cell Therapeutics Market, By Pipeline Product
                                                                                                                                                                                                                          1. AFM13
                                                                                                                                                                                                                            1. MG4101
                                                                                                                                                                                                                              1. GTA002 (oNKordA)
                                                                                                                                                                                                                                1. TAK-007
                                                                                                                                                                                                                              2. Korea
                                                                                                                                                                                                                              3. Japan
                                                                                                                                                                                                                              4. India
                                                                                                                                                                                                                              5. Australia
                                                                                                                                                                                                                              6. Taiwan
                                                                                                                                                                                                                              7. South East Asia
                                                                                                                                                                                                                              8. Rest of Asia-Pacific
                                                                                                                                                                                                                            2. Middle East and Africa
                                                                                                                                                                                                                              1. Middle East and Africa Natural Killer (NK) Cell Therapeutics Market, By Natural Killer (NK) cell Therapy Type
                                                                                                                                                                                                                                1. NK Cell Therapy (unmodified)
                                                                                                                                                                                                                                  1. CAR-NK Cell Therapy (modified)
                                                                                                                                                                                                                                    1. NK Cell Engager
                                                                                                                                                                                                                                    2. Middle East and Africa Natural Killer (NK) Cell Therapeutics Market, By Approaches
                                                                                                                                                                                                                                      1. Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
                                                                                                                                                                                                                                        1. Bispecific Antibodies
                                                                                                                                                                                                                                        2. Middle East and Africa Natural Killer (NK) Cell Therapeutics Market, By Application
                                                                                                                                                                                                                                          1. Cancer
                                                                                                                                                                                                                                            1. Immunoproliferative Disorders
                                                                                                                                                                                                                                              1. Acute Infectious Diseases
                                                                                                                                                                                                                                                1. Gastrointestinal Diseases
                                                                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                                                                  2. Middle East and Africa Natural Killer (NK) Cell Therapeutics Market, By Indication
                                                                                                                                                                                                                                                    1. Hepatocellular Carcinoma (HCC)
                                                                                                                                                                                                                                                      1. Acute Myeloid Leukemia (AML)
                                                                                                                                                                                                                                                        1. Relapsed Or Refractory (r/r) B-Cell Non-Hodgkin's Lymphoma (NHL)
                                                                                                                                                                                                                                                          1. Peripheral T-Cell Lymphoma (PTCL).
                                                                                                                                                                                                                                                          2. Middle East and Africa Natural Killer (NK) Cell Therapeutics Market, By Pipeline Product
                                                                                                                                                                                                                                                            1. AFM13
                                                                                                                                                                                                                                                              1. MG4101
                                                                                                                                                                                                                                                                1. GTA002 (oNKordA)
                                                                                                                                                                                                                                                                  1. TAK-007
                                                                                                                                                                                                                                                                  2. UAE
                                                                                                                                                                                                                                                                    1. UAE Natural Killer (NK) Cell Therapeutics Market, By Natural Killer (NK) cell Therapy Type
                                                                                                                                                                                                                                                                      1. NK Cell Therapy (unmodified)
                                                                                                                                                                                                                                                                        1. CAR-NK Cell Therapy (modified)
                                                                                                                                                                                                                                                                          1. NK Cell Engager
                                                                                                                                                                                                                                                                          2. UAE Natural Killer (NK) Cell Therapeutics Market, By Approaches
                                                                                                                                                                                                                                                                            1. Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
                                                                                                                                                                                                                                                                              1. Bispecific Antibodies
                                                                                                                                                                                                                                                                              2. UAE Natural Killer (NK) Cell Therapeutics Market, By Application
                                                                                                                                                                                                                                                                                1. Cancer
                                                                                                                                                                                                                                                                                  1. Immunoproliferative Disorders
                                                                                                                                                                                                                                                                                    1. Acute Infectious Diseases
                                                                                                                                                                                                                                                                                      1. Gastrointestinal Diseases
                                                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                                                        2. UAE Natural Killer (NK) Cell Therapeutics Market, By Indication
                                                                                                                                                                                                                                                                                          1. Hepatocellular Carcinoma (HCC)
                                                                                                                                                                                                                                                                                            1. Acute Myeloid Leukemia (AML)
                                                                                                                                                                                                                                                                                              1. Relapsed Or Refractory (r/r) B-Cell Non-Hodgkin's Lymphoma (NHL)
                                                                                                                                                                                                                                                                                                1. Peripheral T-Cell Lymphoma (PTCL).
                                                                                                                                                                                                                                                                                                2. UAE Natural Killer (NK) Cell Therapeutics Market, By Pipeline Product
                                                                                                                                                                                                                                                                                                  1. AFM13
                                                                                                                                                                                                                                                                                                    1. MG4101
                                                                                                                                                                                                                                                                                                      1. GTA002 (oNKordA)
                                                                                                                                                                                                                                                                                                        1. TAK-007
                                                                                                                                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                                                                                                                                      1. LATAM Natural Killer (NK) Cell Therapeutics Market, By Natural Killer (NK) cell Therapy Type
                                                                                                                                                                                                                                                                                                        1. NK Cell Therapy (unmodified)
                                                                                                                                                                                                                                                                                                          1. CAR-NK Cell Therapy (modified)
                                                                                                                                                                                                                                                                                                            1. NK Cell Engager
                                                                                                                                                                                                                                                                                                            2. LATAM Natural Killer (NK) Cell Therapeutics Market, By Approaches
                                                                                                                                                                                                                                                                                                              1. Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
                                                                                                                                                                                                                                                                                                                1. Bispecific Antibodies
                                                                                                                                                                                                                                                                                                                2. LATAM Natural Killer (NK) Cell Therapeutics Market, By Application
                                                                                                                                                                                                                                                                                                                  1. Cancer
                                                                                                                                                                                                                                                                                                                    1. Immunoproliferative Disorders
                                                                                                                                                                                                                                                                                                                      1. Acute Infectious Diseases
                                                                                                                                                                                                                                                                                                                        1. Gastrointestinal Diseases
                                                                                                                                                                                                                                                                                                                          1. Others
                                                                                                                                                                                                                                                                                                                          2. LATAM Natural Killer (NK) Cell Therapeutics Market, By Indication
                                                                                                                                                                                                                                                                                                                            1. Hepatocellular Carcinoma (HCC)
                                                                                                                                                                                                                                                                                                                              1. Acute Myeloid Leukemia (AML)
                                                                                                                                                                                                                                                                                                                                1. Relapsed Or Refractory (r/r) B-Cell Non-Hodgkin's Lymphoma (NHL)
                                                                                                                                                                                                                                                                                                                                  1. Peripheral T-Cell Lymphoma (PTCL).
                                                                                                                                                                                                                                                                                                                                  2. LATAM Natural Killer (NK) Cell Therapeutics Market, By Pipeline Product
                                                                                                                                                                                                                                                                                                                                    1. AFM13
                                                                                                                                                                                                                                                                                                                                      1. MG4101
                                                                                                                                                                                                                                                                                                                                        1. GTA002 (oNKordA)
                                                                                                                                                                                                                                                                                                                                          1. TAK-007
                                                                                                                                                                                                                                                                                                                                          2. Brazil
                                                                                                                                                                                                                                                                                                                                            1. Brazil Natural Killer (NK) Cell Therapeutics Market, By Natural Killer (NK) cell Therapy Type
                                                                                                                                                                                                                                                                                                                                              1. NK Cell Therapy (unmodified)
                                                                                                                                                                                                                                                                                                                                                1. CAR-NK Cell Therapy (modified)
                                                                                                                                                                                                                                                                                                                                                  1. NK Cell Engager
                                                                                                                                                                                                                                                                                                                                                  2. Brazil Natural Killer (NK) Cell Therapeutics Market, By Approaches
                                                                                                                                                                                                                                                                                                                                                    1. Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
                                                                                                                                                                                                                                                                                                                                                      1. Bispecific Antibodies
                                                                                                                                                                                                                                                                                                                                                      2. Brazil Natural Killer (NK) Cell Therapeutics Market, By Application
                                                                                                                                                                                                                                                                                                                                                        1. Cancer
                                                                                                                                                                                                                                                                                                                                                          1. Immunoproliferative Disorders
                                                                                                                                                                                                                                                                                                                                                            1. Acute Infectious Diseases
                                                                                                                                                                                                                                                                                                                                                              1. Gastrointestinal Diseases
                                                                                                                                                                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                                                                                                                                                                2. Brazil Natural Killer (NK) Cell Therapeutics Market, By Indication
                                                                                                                                                                                                                                                                                                                                                                  1. Hepatocellular Carcinoma (HCC)
                                                                                                                                                                                                                                                                                                                                                                    1. Acute Myeloid Leukemia (AML)
                                                                                                                                                                                                                                                                                                                                                                      1. Relapsed Or Refractory (r/r) B-Cell Non-Hodgkin's Lymphoma (NHL)
                                                                                                                                                                                                                                                                                                                                                                        1. Peripheral T-Cell Lymphoma (PTCL).
                                                                                                                                                                                                                                                                                                                                                                        2. Brazil Natural Killer (NK) Cell Therapeutics Market, By Pipeline Product
                                                                                                                                                                                                                                                                                                                                                                          1. AFM13
                                                                                                                                                                                                                                                                                                                                                                            1. MG4101
                                                                                                                                                                                                                                                                                                                                                                              1. GTA002 (oNKordA)
                                                                                                                                                                                                                                                                                                                                                                                1. TAK-007
                                                                                                                                                                                                                                                                                                                                                                              2. Mexico
                                                                                                                                                                                                                                                                                                                                                                              3. Argentina
                                                                                                                                                                                                                                                                                                                                                                              4. Chile
                                                                                                                                                                                                                                                                                                                                                                              5. Colombia
                                                                                                                                                                                                                                                                                                                                                                              6. Rest of LATAM

                                                                                                                                                                                                                                                                                                                                                                          Related Reports

                                                                                                                                                                                                                                                                                                                                                                          Global Report
                                                                                                                                                                                                                                                                                                                                                                          The global tool steel market size was valued at USD 5.07 billion in 2021. It is estimated to reach an expected value of USD 8.16 billion by 2030 at a CAGR of 5.3% during the forecast period (2022-2030).  Tool steels are from the carbon ste
                                                                                                                                                                                                                                                                                                                                                                          Buy Now
                                                                                                                                                                                                                                                                                                                                                                          Global Report
                                                                                                                                                                                                                                                                                                                                                                          The global sleep apnea devices market size was valued at USD 4,584.90 million in 2022. It is expected to reach USD 9,405.63 million by 2031, growing at a CAGR of 8.3% during the forecast period (2023–2031). Sleep apnea is a sleeping disorder c
                                                                                                                                                                                                                                                                                                                                                                          Buy Now
                                                                                                                                                                                                                                                                                                                                                                          Global Report
                                                                                                                                                                                                                                                                                                                                                                          The global fire sprinkler market size was valued at USD 12.49 Billion in 2021. It is expected to reach USD 22.26 Billion by 2030, growing at a CAGR of 7.49% during the forecast period (2022–2030). A fire sprinkler system is a straightforward y
                                                                                                                                                                                                                                                                                                                                                                          Buy Now
                                                                                                                                                                                                                                                                                                                                                                          Global Report
                                                                                                                                                                                                                                                                                                                                                                          The global print on demand market was valued at USD 6.3 billion in 2022. It is projected to reach USD 45.6 billion by 2031, growing at a CAGR of 25.3% during the forecast period (2023–2031). E-commerce expansion and the growing trend of online
                                                                                                                                                                                                                                                                                                                                                                          Buy Now
                                                                                                                                                                                                                                                                                                                                                                          Global Report
                                                                                                                                                                                                                                                                                                                                                                          The global platinum market size was valued at USD 7.72 billion in 2022 and is projected to reach USD 11.95 billion by 2031 at a CAGR of 5.13% from 2023 to 2031. Platinum is a crucial component in catalytic converters used to reduce harmful
                                                                                                                                                                                                                                                                                                                                                                          Buy Now

                                                                                                                                                                                                                                                                                                                                                                          Purchase Benefits

                                                                                                                                                                                                                                                                                                                                                                          • Eligible for a free updated report next year
                                                                                                                                                                                                                                                                                                                                                                          • Completely customizable scope
                                                                                                                                                                                                                                                                                                                                                                          • 30% discount on your next purchase
                                                                                                                                                                                                                                                                                                                                                                          • Dedicated account manager
                                                                                                                                                                                                                                                                                                                                                                          • Query resolution within 24 hours
                                                                                                                                                                                                                                                                                                                                                                          • Permission to print the report

                                                                                                                                                                                                                                                                                                                                                                          We are featured on :

                                                                                                                                                                                                                                                                                                                                                                          www.straitsresearch.com
                                                                                                                                                                                                                                                                                                                                                                          © Copyright . All rights Reserved.